DE60201022D1 - Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode - Google Patents

Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode

Info

Publication number
DE60201022D1
DE60201022D1 DE60201022T DE60201022T DE60201022D1 DE 60201022 D1 DE60201022 D1 DE 60201022D1 DE 60201022 T DE60201022 T DE 60201022T DE 60201022 T DE60201022 T DE 60201022T DE 60201022 D1 DE60201022 D1 DE 60201022D1
Authority
DE
Germany
Prior art keywords
lysergol
gaining
efficacy
treatment method
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60201022T
Other languages
English (en)
Other versions
DE60201022T2 (de
Inventor
Suman Preet Singh Khanuja
Jai Shankar Arya
Santosh Kumar Srivastava
Ajit Kumar Shasany
Tiruppadiripuliyur R Kumar
Mahendra Pandurang Darokar
Sushil Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Priority claimed from PCT/IB2002/001125 external-priority patent/WO2003080059A1/en
Publication of DE60201022D1 publication Critical patent/DE60201022D1/de
Application granted granted Critical
Publication of DE60201022T2 publication Critical patent/DE60201022T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60201022T 2002-03-25 2002-03-25 Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode Expired - Lifetime DE60201022T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/001125 WO2003080059A1 (en) 2002-03-25 2002-03-25 Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment

Publications (2)

Publication Number Publication Date
DE60201022D1 true DE60201022D1 (de) 2004-09-23
DE60201022T2 DE60201022T2 (de) 2005-08-18

Family

ID=28053160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60201022T Expired - Lifetime DE60201022T2 (de) 2002-03-25 2002-03-25 Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode

Country Status (6)

Country Link
EP (1) EP1370263B1 (de)
AT (1) ATE273707T1 (de)
AU (1) AU2002247911A1 (de)
CA (1) CA2441629C (de)
DE (1) DE60201022T2 (de)
ES (1) ES2225777T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102134239B (zh) * 2009-12-15 2012-10-24 戈埃尔·帕万·库马 从裂叶牵牛中提取高纯度麦角醇的方法

Also Published As

Publication number Publication date
CA2441629C (en) 2010-09-21
AU2002247911A1 (en) 2003-10-08
EP1370263A1 (de) 2003-12-17
ATE273707T1 (de) 2004-09-15
DE60201022T2 (de) 2005-08-18
EP1370263B1 (de) 2004-08-18
CA2441629A1 (en) 2003-10-02
ES2225777T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
CL2003002287A1 (es) COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
CL2008001813A1 (es) Compuestos derivados de quinolin-3-carbonitrilo sustituidos con piperazina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis, inflamacion, cancer entre otras (div. sol. 266-04).
IL164135A (en) 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer
CL2003002353A1 (es) Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
CL2008002852A1 (es) Compuestos derivados de 7-fluoro-5-metil-2-(fenilamino)-6,7,8,9-tetrahidro-5h-pirimido[4,5-b][1,4]diazepin-6(7h)-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de canceer, inflamacion, alopecia, enfermedades autoinmune, cardiovasculares, infecciosas, nefrologicas, neurodfegenerativas, cutaneas y oseas.
EA200602047A1 (ru) Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
WO2004103311A3 (en) Antibiotic composition
TW200501947A (en) Stabilized pharmaceutical composition comprising an amorphous active substance
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
IL163951A (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
ATE446763T1 (de) Pharmazeutische formulierung zur behandlung von osteoarthritis mit clodronsäure und hyaluronsäure
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
DE60201022D1 (de) Antibiotische pharmazeutische formulierung mit lysergol zur verstärkung der wirksamkeit und behandlungsmethode
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados
WO2003080568A3 (en) Probucol derivatives
BR0316021A (pt) Comibinação compreendendo um inibidor de cdk e cisplatina
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
AR046245A1 (es) Sales de calcio de rabeprazol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition